Statement regarding authorization to purchase outstanding Contingent Value Rights (CVRs) Sanofi has obtained the necessary corporate authorizations to purchase any or all of the outstanding Contingent Value Rights ( CVR
Thursday, November 17, 2011 1 min read
Key Takeaway: Statement regarding authorization to purchase outstanding
Contingent Value Rights (CVRs)
Sanofi has obtained the necessary corporate authorizations to purchase any or all of the outstanding Contingent Value Rights ( CVR ). Sanofi intends for any purchases to be made through ope
Full Press Release Details
Statement regarding authorization to purchase outstanding
Contingent Value Rights (CVRs)
Sanofi has obtained the necessary corporate authorizations to purchase any or all of the outstanding Contingent Value Rights ( CVR ). Sanofi intends for any purchases to be made through open
market purchases as permitted by the CVR Agreement and subject to applicable requirements under securities laws and Nasdaq Stock Market rules.